Ascletis Pharma, Inc.'s total assets for Q2 2025 were ¥2.00B, a decrease of -6.01% from the previous quarter. HK:1672 total liabilities were ¥129.00M for the fiscal quarter, a -18.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.